Sang-Joon Lee
Chief Executive Officer at HYUNDAI PHARMACEUTICAL CO., LTD.
Net worth: 4 M $ as of 2024-03-30
Profile
Sang-Joon Lee is currently the President, CEO, Director, and Head of R&D at Hyundai Pharmaceutical Co., Ltd.
He is also the Chief Executive Officer at Bioinnotis.
Mr. Lee holds an MBA from the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-27 | 1,351,612 ( 4.22% ) | 4 M $ | 2024-03-30 |
Sang-Joon Lee active positions
| Companies | Position | Start |
|---|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 2003-02-27 |
Bioinnotis
 Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Chief Executive Officer | - |
Training of Sang-Joon Lee
| University of San Diego | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Bioinnotis
Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Commercial Services |
- Stock Market
- Insiders
- Sang-Joon Lee
